acetylglucosamine has been researched along with Hypertrophy, Left Ventricular in 2 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 2 (100.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Vlasselaers, D | 1 |
Ashrafian, H; Bonser, RS; Calvert, M; Contractor, H; Drury, NE; Freemantle, N; Frenneaux, M; Graham, TR; Green, D; Howell, NJ; Isackson, H; Mascaro, JG; Pagano, D; Quinn, DW; Ranasinghe, AM; Rooney, SJ; Williams, LK; Wilson, IC | 1 |
1 trial(s) available for acetylglucosamine and Hypertrophy, Left Ventricular
Article | Year |
---|---|
Glucose-insulin-potassium reduces the incidence of low cardiac output episodes after aortic valve replacement for aortic stenosis in patients with left ventricular hypertrophy: results from the Hypertrophy, Insulin, Glucose, and Electrolytes (HINGE) trial
Topics: Acetylglucosamine; Aged; AMP-Activated Protein Kinases; Aortic Valve; Aortic Valve Stenosis; Cardiac Output, Low; Double-Blind Method; Female; Glucose; Heart Valve Prosthesis; Humans; Hypertrophy, Left Ventricular; Incidence; Insulin; Male; Middle Aged; Phosphatidylinositol 3-Kinases; Potassium; Proto-Oncogene Proteins c-akt; Risk Factors; Treatment Outcome | 2011 |
1 other study(ies) available for acetylglucosamine and Hypertrophy, Left Ventricular
Article | Year |
---|---|
Glucose-insulin-potassium: much more than enriched myocardial fuel.
Topics: Acetylglucosamine; AMP-Activated Protein Kinases; Aortic Valve Stenosis; Cardiac Output, Low; Glucose; Humans; Hypertrophy, Left Ventricular; Insulin; Myocardium; Phosphatidylinositol 3-Kinases; Potassium; Proto-Oncogene Proteins c-akt; Risk Factors | 2011 |